Presented by
Good morning, AI enthusiasts. A Sydney tech entrepreneur just did what a major pharmaceutical company refused to do, design a personalized cancer vaccine for his dying dog using ChatGPT and DNA analysis. Early results show the main tumour on her leg has already halved.
In today's recap:
Microsoft brings AI to your health records
ChatGPT helped design a dog's cancer vaccine
Anthropic doubles Claude usage through March 27
Eight tech giants sign an anti-scam accord
3 new AI tools, prompts, and more
MICROSOFT
Microsoft launches an AI that reads your medical records
Microsoft
Recaply: Microsoft just launched Copilot Health, a secure Copilot tab that connects health records, wearables, and lab results to give users personalized health insights, joining OpenAI and Anthropic in the consumer health AI market.
Key details:
Copilot Health appears as a tab in Copilot's web and mobile apps. Users connect wearables, health records, and lab results, then ask AI to surface patterns and help prepare questions for doctor visits.
Microsoft's AI already fields 50 million health questions a day. Copilot Health connects to 52,000+ US healthcare providers and more than 50 wearable devices, including Apple Health, Oura, and Fitbit.
Copilot Health isn't covered by HIPAA. Microsoft VP Dominic King told press briefings the law doesn't apply to direct-consumer products, though he said HIPAA controls are coming.
Copilot Health opened its waitlist on March 12, 2026. It's rolling out in phases to English-speaking US adults aged 18 and older, with health data not used for model training.
Why it matters: While Copilot Health could help millions of people understand their own health, it asks users to share their most sensitive data with Microsoft without HIPAA protections in place. That's a real tension. With OpenAI and Anthropic already moving into consumer health AI, the race to become people's go-to health companion is fully underway, and 2026 looks like the year it gets decided.
PRESENTED BY BELAY
Speed Doesn’t Replace Strategy.
AI can surface the numbers in seconds, but numbers alone don’t create clarity.
In fact, many leaders have more financial data than ever yet less clarity about what to do next.
The real challenge isn’t reporting. It’s interpretation. Context. Judgment.
BELAY created the free guide The Future of Financial Leadership to explore why automation is a tool — not a replacement — for experienced financial oversight.
Inside, you’ll learn how the right human support brings structure to your numbers, confidence to your decisions, and focus to your growth strategy.
At BELAY, our U.S.-based Financial Experts help leaders move beyond dashboards and into decisive action.
Because insight doesn’t drive a business forward. Leadership does.
AI RESEARCH
ChatGPT just helped design a dog's cancer vaccine
The Australian
Recaply: A Sydney tech entrepreneur just used ChatGPT and DNA analysis to help design a cancer vaccine for his dog Rosie, with early results showing the main tumour on her leg has halved.
Key details:
Paul Conyngham worked with UNSW scientists to sequence Rosie's tumour DNA. He then used ChatGPT and AlphaFold to map cancer-driving mutations and build a vaccine blueprint.
The UNSW sequencing cost $3,000 and compared Rosie's healthy DNA with tumour DNA to find the mutations. Conyngham condensed his findings into a half-page formula that scientist Pall Thordarson used to build the vaccine.
According to Interesting Engineering, Thordarson said it was the first time a personalised cancer vaccine had been designed for a dog, adding it shows how quickly mRNA technology can be deployed.
Rosie received her first injection in December 2025, with booster doses in early 2026 through a University of Queensland research programme led by Rachel Allavena.
Why it matters: There's something quietly remarkable about a tech entrepreneur using ChatGPT and a $3,000 DNA kit to do what a pharmaceutical company refused. The treatment is still experimental, and Rosie is just one dog. But researchers say the case shows how AI can shorten the path from genetic data to personalised treatment, with real implications for how human cancer vaccines get made.
NEWS
What Matters in AI Right Now?
Google introduced Ask Maps and Immersive Navigation to Google Maps, with Ask Maps answering conversational questions about places and Immersive Navigation offering new 3D visuals and real-time route updates for drivers.
A Florida homeowner sold his home in five days using ChatGPT for pricing, marketing, and contract drafting, getting five offers in 72 hours and saving roughly 3% by skipping a real estate agent.
Anthropic launched the Claude Certified Architect exam, a proctored 60-question test for partner company developers, with early access free for the first 5,000 applicants and general availability at $99.
Anthropic is doubling usage limits for Claude during off-peak hours for Free, Pro, Max, and Team users through March 27, with the offer running on web, desktop, mobile, and Claude Code.
ZAI released GLM-5-Turbo, a faster version of GLM-5 built for quick agentic tasks and agent workflows, following the full model launch in February with 744B parameters.
Google, Meta, Amazon, and OpenAI signed a new scam-fighting accord with four other tech companies, pledging to share threat data and use AI to protect users ahead of the UN Global Fraud Summit.
TOOLS
Trending AI Tools
🤖 GLM-5-Turbo - ZAI’s fast model for agent workflows
🗺️ Ask Maps - Google’s new AI-powered for Maps
💡 Claude - Anthropic’s AI now doubles usage limits alongside the launch of the Claude Certified Architect program.
🧡 Enjoyed this issue?
🤝 Recommend our newsletter or leave a feedback.
How'd you like today's newsletter?
Cheers, Jason
